Tech to Save Moms Act
Summary
HR8317, the Tech to Save Moms Act, has been introduced in the House and referred to the Committee on Energy and Commerce. The bill authorizes grants for technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, particularly in underserved areas. No specific funding amount is authorized, and actual appropriations would be required for implementation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8317, the Tech to Save Moms Act, has been introduced in the House and referred to the Energy and Commerce Committee.
- 2.The bill authorizes grants for technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, but does not appropriate funds.
- 3.Companies in the telehealth and health technology sectors are potential beneficiaries if the bill passes and receives appropriations.
Market Implications
The introduction of HR8317 signals legislative intent to expand the use of technology in maternal healthcare. Should this bill advance and receive appropriations, it would create new grant opportunities for eligible entities to adopt and expand telehealth solutions. This could translate into increased demand for services from telehealth providers like Teladoc Health ($TDOC) and Amwell ($AMWL), as well as companies offering remote monitoring and diagnostic technologies. The bill's focus on underserved populations could open new market segments for these companies. However, as the bill is in an early stage and only authorizes grants without appropriating funds, any market impact is currently speculative and contingent on future legislative action.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Distance Learning and Telemedicine Grants Program to expand eligibility for financial assistance to include the construction and enhancement of facilities and technological systems aimed at delivering telemedicine services, strengthening cybersecurity infrastructure, and supporting distance learning initiatives, including digital literacy, workforce development, and job training, in rural communities.
To amend the Public Health Service Act with respect to the Living Organ Donation Reimbursement Program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
SCREENS for Cancer Act of 2025
PrEP and PEP are Prevention Act
Thyroid Disease CARE Act of 2025
Access to Breast Cancer Diagnosis Act of 2025
Supporting Healthy Moms and Babies Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.